Müller Uta, Hämmerlein Andrea, Casper Annette, Schulz Martin
Center for Drug Information and Pharmacy Practice, ABDA - Federal Union of German Associations of Pharmacists. Berlin ( Germany ).
Center for Drug Information and Pharmacy Practice, ABDA, Berlin ( Germany ).
Pharm Pract (Granada). 2006 Oct;4(4):195-203. doi: 10.4321/s1885-642x2006000400008.
Self-monitoring of blood glucose (SMBG) is clearly correlated with increased life expectancy and quality of life in type 2 diabetic patients.
The objective of our study was to record and assess the errors patients make in preparing, performing, and processing self-monitoring of blood glucose (SMBG). Furthermore, the study aimed to determine to what extent a single standardized SMBG instruction session in a community pharmacy might reduce the number of patients making errors or the number of errors per patient.
Between May and October 2005, SMBG of 462 randomly selected patients with type 2 diabetes was monitored in 32 pharmacies specialized in diabetes care. The patients performed blood glucose self-tests using their own blood glucose meters. Self-testing was monitored using a standardized documentation sheet on which any error made during the performance of the test was recorded. If necessary, patients were instructed in the accurate operation of their meter and the use of the necessary equipment. Additionally, patients obtained written instructions. Six weeks later, assessment of the quality of patient's SMBG was repeated.
During the first observation, 383 patients (83%) made at least one mistake performing SMBG. By the time of the second observation, this frequency had fallen to 189 (41%) (p<0.001). The average number of mistakes fell from 3.1 to 0.8 per patient. Mistakes that may potentially have led to inaccurate readings were initially recorded for 283 (61%) and at study end for 110 (24%) patients (p<0.001).
It is important to periodically instruct type 2 diabetic patients in the proper SMBG technique in order to ensure accurate measurements. In this study it was shown that community pharmacies specialized in diabetes care can provide this service effectively.
自我血糖监测(SMBG)与2型糖尿病患者预期寿命和生活质量的提高明显相关。
我们研究的目的是记录和评估患者在准备、进行和处理自我血糖监测(SMBG)时所犯的错误。此外,该研究旨在确定社区药房一次标准化的SMBG指导课程在多大程度上可以减少犯错患者的数量或每位患者的错误数量。
2005年5月至10月期间,在32家专门提供糖尿病护理的药房中,对462名随机选取的2型糖尿病患者的自我血糖监测情况进行了监测。患者使用自己的血糖仪进行血糖自我检测。使用标准化的记录表格对自我检测进行监测,该表格记录检测过程中出现的任何错误。如有必要,指导患者正确操作血糖仪和使用必要设备。此外,患者还获得了书面指导。六周后,再次评估患者自我血糖监测的质量。
在首次观察期间,383名患者(83%)在进行自我血糖监测时至少犯了一个错误。到第二次观察时,这一频率降至189名(41%)(p<0.001)。每位患者的平均错误数量从3.1个降至0.8个。最初有283名(61%)患者被记录存在可能导致读数不准确的错误,而在研究结束时,这一数字为110名(24%)患者(p<0.001)。
定期指导2型糖尿病患者掌握正确的自我血糖监测技术以确保测量准确非常重要。本研究表明,专门提供糖尿病护理的社区药房能够有效提供这项服务。